Vimarsana
Biggest News Aggregation in the World

Page 10 - Peter Luo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Luo. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Luo Today - Breaking & Trending Today

POV: Wuhan Wuhan - Vimarsana News

POV: Wuhan Wuhan

Premieres Monday, July 11, 2022 at 10:30 p.m. on KPBS TV / On demand with PBS Video App. With unprecedented access in a period of pandemic lockdown, the film documents February and March 2020 in Wuhan where the coronavirus was first discovered. Going beyond the statistics and salacious headlines, frontline medical workers, patients, and ordinary citizens put a human face on the early days of the mysterious virus as they grapple with an invisible, deadly killer.

Source: kpbs.org
China's Economy, Geopolitical Risk and Zero Covid Policies - Vimarsana News

China's Economy, Geopolitical Risk and Zero Covid Policies

China will be a headline in the U.S. for the coming decades, as its top strategic competitor. Let’s detangle various aspects of this competition.

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China - Press Release - Vimarsana News

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China - Press Release

SYDNEY, June 6, 2022 - (ACN Newswire) - Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US,

Biotech and Delisting Risk From China's Perspective with WisdomTree - Vimarsana News

Biotech and Delisting Risk From China's Perspective with WisdomTree

Liqian Ren, Ph.D. and director of modern alpha for WisdomTree, spoke with Dr. Peter Luo, Ph.D, co-founder and CEO of Adagene, regarding developments in the pharmaceutical industry and business practices abroad.

Adagene Presents Data Demonstrating First and Best-in-Class Potential for Differentiated Preclinical Antibody Candidates at American Association for Cancer Research (AACR) Annual Meeting 2022 - Vimarsana News

Adagene Presents Data Demonstrating First and Best-in-Class Potential for Differentiated Preclinical Antibody Candidates at American Association for Cancer Research (AACR) Annual Meeting 2022

- Poster presentations showcase SAFEbody® precision masking technology applicability across targets and modalities – ...